Scientists have discovered what could be promising new targets for combination therapy for the treatment of Alzheimer's disease.
Researchers at the University of Illinois at Chicago College of Medicine believe a one-two punch of therapy could combat the neurodegenerative disease.
Alzheimer's is characterised by two protein malformations, although no[hypen?]one has yet explained how they damage the nervous system.
The new research reveals the actions of the proteins in the brain and shows that treatment of both malformations is necessary to treat the disease, explaining why focusing on one or the other is not successful.
Combination therapies could be used to address many targets at once and tackle Alzheimer's, the study points out.
Earlier this month, researchers at the University of Pennsylvania School of Medicine unveiled a test that can confirm or rule out the neurodegenerative disease.
By measuring cerebrospinal fluid concentrations, the test can also predict if mild cognitive impairment will lead to Alzheimer's.
Please click here for advice to help you find the right type of care.